Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-05-12Clinical Trial Update: Reducing Breast Cancer-related Fatigue and Improving Cognition With Non-Invasive Brain Stimulation [NA]
A terminated clinical trial investigating non-invasive brain stimulation to reduce breast cancer–related fatigue and improve cognition; resu…
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA [Phase 2]
Phase 2 trial results evaluating the combination of T-DM1 (ado-trastuzumab emtansine) and pertuzumab as neoadjuvant therapy for early-stage …
-
CLINICAL_TRIALS withdrawal · 2021-05-10Clinical Trial Update: To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer. [Phase 3]
Clinical trial comparing ZOLADEX 10.8 mg vs 3.6 mg in Chinese pre-menopausal ER+ HER2- early breast cancer was withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy [Phase 3]
Phase 3 trial evaluating F-627 (Neulasta-controlled) in women with breast cancer undergoing myelotoxic chemotherapy has completed and posted…
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Bevacizumab, Etoposide and Cisplatin Followed by Whole Brain Radiotherapy in Breast Cancer With Brain Metastases [Phase 2]
Phase 2 trial evaluating bevacizumab, etoposide, and cisplatin followed by whole brain radiotherapy for breast cancer with brain metastases.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Hypofractionated Radiotherapy in Breast Cancer [NA]
A completed clinical trial update on hypofractionated radiotherapy for breast cancer, with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-05Clinical Trial Update: Study of Ribociclib With Everolimus + Exemestane in HR+ HER2- Locally Advanced/Metastatic Breast Cancer Post Progression on CDK 4/6 Inhibitor. [Phase 1, Phase 2]
A study evaluating ribociclib in combination with everolimus and exemestane in HR-positive, HER2-negative locally advanced or metastatic bre…
-
CLINICAL_TRIALS trial_result · 2021-05-04Clinical Trial Update: Optoacoustic Images Versus Imagio® Ultrasound [NA]
Clinical trial update comparing Optoacoustic imaging to Imagio ultrasound for breast cancer; study completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-03Clinical Trial Update: Effects of GnRHa on Ovarian Function Against Chemotherapy-induced-gonadotoxicity [Phase 3]
Phase 3 trial evaluating GnRHa to protect ovarian function during chemotherapy-induced gonadotoxicity in breast cancer patients; study compl…
-
CLINICAL_TRIALS trial_result · 2021-05-03Clinical Trial Update: Effectiveness of Screening and Brief Interventions for Alcohol and Tobacco During Breast Cancer Treatment (ONKODETOX) [NA]
Completed trial investigating screening and brief interventions for alcohol and tobacco use during breast cancer treatment; results posted i…
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC) [Phase 3]
Phase 3 trial of sacituzumab govitecan in refractory/relapsed metastatic triple-negative breast cancer has completed; results posted in 2021…
-
CLINICAL_TRIALS trial_result · 2021-04-29Clinical Trial Update: Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2 [Phase 3]
Phase 3 trial update evaluating doxorubicin and cyclophosphamide plus paclitaxel with or without trastuzumab in node-positive, HER2-overexpr…
-
CLINICAL_TRIALS research · 2021-04-29Clinical Trial Update: Clinical Utility of a Low-Cost Hand-Held Breast Scanner [NA]
Clinical trial update on a low-cost hand-held breast scanner for symptomatic breast lump; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-27Clinical Trial Update: Phase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BC [Phase 2]
Phase II trial of pembrolizumab with palliative radiotherapy in metastatic breast cancer was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: Neoadjuvant Treatment With Palbociclib and Exemestane Plus Trastuzumab and Pyrotinib in Estrogen Receptor (ER)-Positive, HER2-positive Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating neoadjuvant therapy combining palbociclib, exemestane, trastuzumab, and pyrotinib in ER-positive, HER2-pos…
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer [Phase 2]
Phase 2 trial evaluating patient preference and satisfaction with subcutaneous administration of the fixed-dose combination of pertuzumab an…
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: MEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast Cancer [Phase 2]
Phase 2 trial update evaluating MEDI4736 (durvalumab) and tremelimumab in metastatic HER2-negative breast cancer has completed with posted r…
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: A Study of GDC-0810 Versus Fulvestrant in Postmenopausal Women With Advanced or Metastatic Breast Cancer Resistant to Aromatase Inhibitor (AI) Therapy [Phase 2]
Phase 2 trial comparing GDC-0810 with fulvestrant in postmenopausal women with advanced/metastatic breast cancer resistant to aromatase inhi…
-
CLINICAL_TRIALS trial_result · 2021-04-21Clinical Trial Update: Ruxolitinib W/ Preop Chemo For Triple Negative Inflammatory Brca [Phase 1, Phase 2]
Phase 1/2 study evaluating ruxolitinib in combination with preoperative chemotherapy for triple-negative inflammatory breast cancer; study c…
-
CLINICAL_TRIALS trial_result · 2021-04-20Clinical Trial Update: Ultrasound Guided Rhomboid Intercostal and Subserratus Plane Block in Breast Cancer Surgeries [Phase 4]
A Phase 4 clinical trial evaluating ultrasound-guided rhomboid intercostal and subserratus plane block for postoperative analgesia in breast…
-
CLINICAL_TRIALS trial_result · 2021-04-20Clinical Trial Update: Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer [NA]
Completed trial update on multi-beam intensity-modulated radiation therapy for node-positive breast cancer; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC) [Phase 1]
Phase 1 pilot study evaluating reparixin with weekly paclitaxel in HER2-negative metastatic breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-14Clinical Trial Update: Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation [Phase 4]
Phase 4 trial update evaluating riluzole's effects on CNS glutamate and fatigue in breast cancer survivors with high inflammation.
-
CLINICAL_TRIALS trial_result · 2021-04-14Clinical Trial Update: A Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating standard chemotherapy with metformin versus placebo in women with metastatic breast cancer; study completed with re…
-
CLINICAL_TRIALS trial_result · 2021-04-13Clinical Trial Update: Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer [Phase 2]
Phase 2 trial evaluating whole-brain radiation therapy or stereotactic radiosurgery with or without lapatinib for brain metastases from HER2…